No Detail Found!

Association between Left Ventricular Thrombus Formation and Adverse Outcomes in Acute Anterior Myocardial Infarction Patients who had Undergone Primary Percutaneous Coronary Intervention

Author(s)
SAADAT HUSSAIN CPEIC Multan/MMDC Multan.Pakistan
HAFIZ ABDUL KABEER CPEIC Multan/MMDC Multan.Pakistan
AMIR SHAHZAD CPEIC Multan/MMDC Multan.Pakistan
MIAN ADNAN ASLAM CPEIC Multan/MMDC Multan.Pakistan
Abstract
To investigate the association between left ventricular thrombosis (LVT) and adverse cardio-cerebrovascular events in anterior acute ST segment elevation myocardial infarction patients who had undergone primary percutaneous coronary intervention. Study design: A retrospective study. Study place and duration: From 22nd Oct 2020 to 22nd Oct 2021 at the Cardiology department of Ch.Pervaiz Elahi Institute of Cardiology Multan. Methodology: The study included patients who were identified with anterior acute ST segment elevation myocardial infarction and received primary percutaneous intervention within the first 12 hours following onset. Patients were specifically evaluated for being treated with oral vitamin K antagonists (VKA) at discharge along with their assessment of the international normalized ratio (INR). The primary endpoint was considered as the occurrence of major cardio-cerebrovascular events, the secondary endpoint was the resolution of thrombus in LVT patients within 1 year. Results: 4(6.6%) patients were diagnosed with LVT within a month after disease onset and 56(93%) without LVT. During one year follow up, 6(10%) patients without LVT and 1(22%) patient with LVT had gone through MACCE event at least once. According to univariate analysis, LVT is related to an increase in the risk of MACCE events. The rate of heart failure differed significantly (OR = 3.42, 95% CI (1.3-4.6)). Within a year of onset, LVT was an independent predictor of MACCE (HR =2.3, 95% CI (1.11-6.40)). Moreover, in patients with INR = 2 risk of MACCE was less as compared to those with INR < 2. Conclusion: LVT is an independent predictor of 1 year adverse cardio-cerebrovascular events in subjects with ant-AMI who had undergone PPCI. Within therapeutic range =2 treatment consists of triple therapy. It can potentially reduce the rate of MACCE events and increase the dissolution of the thrombosis.
Publication Details
Page(s) 29-31
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
, primary cutaneous infarction, anterior myocardial infarction, adverse coronary outcomes, Left venous thrombosis
References
Lee SH,Lee S-R,J-K Kim W-H .2019 .Usefulness of myocardial longitudinal strain in prediction of heart failure in patients with successfully reperfused anterior wall ST-segment elevation myocardial infarction. Korean Circulation Journal, 49(10) : 960-72.
Ram P,Shah M,Lo KB,Figueredo V .2018 .Reply: surprisingly low incidence of left ventricular thrombosis in anterior ST‐segment elevation myocardial infarction. Clinical Cardiology, 41(10) : 1298.
Caro-Dominguez P,Yoo S-J,Seed M,Grosse-Wortmann L M .2018 .Magnetic resonance imaging of cardiovascular thrombi in children. Pediatric Radiology, 48(5) : 722-31.
Chaosuwannakit N,Makarawate P.,Left Ventricular P. .2021 .Thrombi: Insights from Cardiac Magnetic Resonance Imaging. , 7(2) : 180-8.
Weinsaft JW,Kim HW,Crowley AL,Klem I,Shenoy C,Van Assche L .2011 .LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC: Cardiovascular Imaging, 4(7) : 702-12.
Maniwa N,Fujino M,Nakai M,Nishimura K,Miyamoto Y,Kataoka Y .2018 .Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction. European heart journal, 39(3) : 201-8.
McCarthy CP,Vaduganathan M,McCarthy KJ,Januzzi JL,Bhatt DL,McEvoy JW .2018 .Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA cardiology, 3(7) : 642-9.
Aguilera-Alvarez V,Odeyinka O,Lopez A .2021 .Role of thrombotic thrombocytopenic purpura in myocardial infarction for elevation of ST segment. Journal of Advanced Medical and Dental Sciences Research, 9(10) : 62-6.
January CT,Wann LS,Alpert JS,Calkins H,Cigarroa JE,Cleveland JC .2014 .AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21) : e1-e76.
Ozaki Y,Hara H,Onuma Y,Katagiri Y,Amano T,Kobayashi Y .2022 .Cardiovascular intervention and therapeutics. , : 1-34.
Garber AM,Mentz RJ,Al-Khalidi HR,Shaw LK,Fiuzat M,O'Connor CM .2016 .Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction. Journal of thrombosis and thrombolysis, 41(3) : 365-73.
Rodriguez JBC,Okajima K,Greenberg BH .2021 .Management of left ventricular thrombus: a narrative review. Annals of Translational Medicine, 9(6) : .
Li XY,Su GH,Wang GX,Hu HY,Fan CJ .2018 .Switching from ticagrelor to clopidogrel in patients with ST‐segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real‐world China: occurrences, reasons, and long‐term clinical outcomes. Clinical cardiology, 41(11) : 1446-54.
Gianstefani S,Douiri A,Delithanasis I,Rogers T,Sen A,Kalra S .2014 .Incidence and predictors of early left ventricular thrombus after STelevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention. The American journal of cardiology, 113(7) : 1111-6.
Vaitkus PT,Barnathan ES .1993 .Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. Journal of the American College of Cardiology, 22(4) : 1004-9.
Smits PC,Frigoli E,Tijssen J,Jüni P,Vranckx P,Ozaki Y .2021 .Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an openlabel, randomized, controlled trial. Circulation, 144(15) : 1196-211.
0

Citations

0

Downloads

65

Views